<DOC>
	<DOCNO>NCT02029144</DOCNO>
	<brief_summary>Dydrogesterone widely use worldwide various gynecological obstetric indication : - Dydrogesterone effective cycle regulation treatment . - Dydrogesterone recognize none interference hypothalamus pituitary ovary ( HPO ) axis recommend dosage . - Dydrogesterone might non-negative effect glucose lipid metabolic .</brief_summary>
	<brief_title>Observational Study Dydrogesterone Cycle Regularization</brief_title>
	<detailed_description>The current study design prospective , non-interventional , observational study . Patients irregular cycle diagnose AUB-O prescribe dydrogesterone per physician 's clinical practice .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<criteria>Women age 16 year menses Patient suffer irregular menstrual cycle least 3 month diagnose AUBO ( irregular cycle define cycle duration ＜ 21days ＞35 day ) Physicians decide prescribe dydrogesterone 10mg cycle regulation treatment , orally take dydrogesterone 10mg twice daily , day16 day 25 cycle , consecutive least 3 cycle Patient willing sign write authorization Hyperprolactinemia thyroid dysfunction . Patient take cycle regulation treatment include oral contraceptive , sex hormone glucocorticoid past 1 month Women estrogen deficiency relate symptom Patient meet contraindication list Chinese label dydrogesterone Pregnant lactating patient Patient suitable study accord physician 's discretion</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>